Baricitinib for Reduction of HIV - CNS

Clinical trial NCT05452564 · RECRUITING

Trial details

NCT number: NCT05452564
Sponsor: William Tyor
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2023-05-18
Primary completion: 2028-01-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.